Patent ID: 8466141

Claim:
A method of treating a disease syndrome selected from the group consisting of obesity and type 2 diabetes, comprising administering to the subject a pharmaceutical composition comprising: (a) a therapeutically effective amount of a compound represented by Formula I: wherein R 1 and R 2 are each independently hydrogen, halogen, alkoxy, hydroxy or lower alkyl having 1 to 6 carbon atoms; R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are each independently hydrogen, hydroxy, C 1 -C 20 alkyl, alkene, alkoxy, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, or two substituents of R 3 to R 8 may be taken together to form a cyclic structure; and n is 0 or 1, with proviso that when n is 0, carbon atoms adjacent to n form a cyclic structure via a direct bond, or a pharmaceutically acceptable salt; and (b) a pharmaceutically acceptable carrier, a diluent, an excipient, or any combination thereof.